Skip to search.
 TSX Up 0.30% TSX Ventures Up 1.29%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
0.81 Down 0.04(4.71%) 1:34PM EDT
Prev Close:0.85
Open:0.82
Bid:0.76 x 400
Ask:0.81 x 1000
1y Target Est:1.57
Beta:2.74048
Next Earnings Date:N/A
Day's Range:0.76 - 0.86
52wk Range:0.74 - 9.30
Volume:24,004
Avg Vol (3m):79,706
Market Cap:31.49M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :-0.37
Quarterly EPS Est (Sep-15) :N/A
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. The company's lead central nervous system drug candidate is ELND005, which has completed a Phas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback